Itaconix Reports Record First-Half Revenue, Lifts 2026 Guidance on Strong Product Growth

SPARX Formulated Solutions grew in North America driven by increased use of SPARX formulations for solid unit-dose dish and laundry detergents, with revenues also coming from other key ingredients that contract manufacturers need to produce SPARX formulations.
Performance Ingredients expansion included a new unit-dose dish detergent customer in the EMEA region and a new unit-dose laundry detergent customer in North America, highlighting regional unit-dose demand.
Shares rose about 18.72% to 139.5p following the trading update, signaling investor optimism.
H1 2026 revenue was 46% higher than H2 2025, underscoring momentum across product lines.
Market chatter notes H1 2026 EBITDA around $300,000, suggesting the company is not yet profitable despite revenue growth.
Itaconix, a maker of plant-based polymers, reported record first-half revenue of $8.3 million — a 72% jump from the same period last year. MarketScreener reported the company also raised its full-year 2026 revenue guidance to at least $14.8 million, well above market expectations of around $13.3 million.
Shares surged about 18.72% to 139.5p following the update, according to Stock Invest. The company said it remains on track to hit a small positive EBITDA for the full year, even as it keeps investing in growth.
H1 2026 revenue came in 46% higher than H2 2025, showing strong momentum across the business. Growth came from both existing customers and new detergent brands in Europe and North America. MarketScreener noted the company was "pleased with progress" across its key segments.
The gross profit margin is expected to hold steady at around 36%, in line with FY2025. That reflects tight control of raw materials and supply chains. Despite that margin strength, early estimates put H1 2026 EBITDA at only around $300,000 — meaning the company is not yet clearly profitable.
Itaconix added a new unit-dose dish detergent customer in the EMEA region and a new unit-dose laundry detergent customer in North America. Both wins sit in its Performance Ingredients segment. Unit-dose detergents are small, pre-measured pods used in dishwashers and washing machines — a fast-growing format.
Its SPARX Formulated Solutions business also grew in North America. That growth came from wider use of SPARX formulations in solid unit-dose dish and laundry products. Revenues also came from other ingredients that contract manufacturers need to make SPARX formulations, adding another layer of demand.
Beyond detergents, Itaconix is making progress in two newer areas. Its BIO*Asterix product line covers specialty monomers and binders used in paints. Its BioVail ingredient targets plant nutrition — a completely different market from cleaning products.
These segments are still early-stage but show the company is building a broader portfolio. The strategy reduces reliance on any single product line, which matters as Itaconix pushes toward sustained profitability.
The new full-year guidance of at least $14.8 million sits well above the prior market consensus of about $13.3 million. Investing.com reported shares hit 137.50 pence on the day of the update, a 17% single-day gain. Stock Invest put the move even higher, at roughly 18.72%, closing at 139.5p.
The sharp share price move signals that investors believe Itaconix can keep its growth going. The company still needs to convert strong revenue into clear profitability. But with guidance now beating expectations and new customers landing on both sides of the Atlantic, the mid-term outlook looks increasingly solid.
Publishers
15
Articles
28
Reach
43